NVP-AEW541
Catalog No. A11021
NVP-AEW541是一种选择性的IGF-1R激酶抑制剂,可抑制IGF-1R的自磷酸化活性(IC50 = 0.086 uM)并阻止IGF-1介导的MCF-7细胞存活和增殖(IC50分别为0.16和1.64 uM)。
- Tsushima H, .et al. Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis, Autoimmunity, 2017, Aug;50(5):329-335 PMID: 28682648
Catalog Num | A11021 |
---|---|
M. Wt | 439.6 |
Formula | C27H29N5O |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 475489-16-8 |
Synonyms | AEW541 |
SMILES | C1CN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6 |
NVP-AEW541是一种选择性的IGF-1R激酶抑制剂,可抑制IGF-1R的自磷酸化活性(IC50 = 0.086 uM)并阻止IGF-1介导的MCF-7细胞存活和增殖(IC50分别为0.16和1.64 uM)。
In vitro (25°C) | DMSO | 77 mg/mL (175.18 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 19 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.75 mL | 113.74 mL | 227.48 mL |
0.5 mM | 4.55 mL | 22.75 mL | 45.5 mL |
1 mM | 2.27 mL | 11.37 mL | 22.75 mL |
5 mM | 0.45 mL | 2.27 mL | 4.55 mL |
*The above data is based on the productmolecular weight 439.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.